Genetic clues to understanding periodic fevers, and possible therapies

Trends in Molecular Medicine

Volumn 8, Issue 12, 2002, Pages 550-554

  McDermott, Michael F ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; COLCHICINE; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 1; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

AMYLOIDOSIS; APOPTOSIS; CELL SURVIVAL; CROHN DISEASE; FEVER; GENE MUTATION; GENETIC ANALYSIS; HEREDITARY PERIODIC FEVER SYNDROME; HUMAN; INFLAMMATION; LEUKOCYTE; MOLECULAR RECOGNITION; PATHOGENESIS; RECURRENT DISEASE; REVIEW; SIGNAL TRANSDUCTION; SYNDROME; TUBERCULOSIS;

EID: 0036892403     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02425-5     Document Type: Review

References (55)

1. Drenth, J.P. and van der Meer, J.W. (2001) Hereditary periodic fever. N. Engl. J. Med. 345, 1748-1757
2. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797-807
3. The French FHF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat. Genet. 17, 25-31
4. Fairbrother, W.J. et al. (2001) The PYRIN domain: A member of the death domain-fold superfamily. Protein Sci. 10, 1911-1918
5. Martinon, F. et al. (2002) The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 1-20
6. Manji, G.A. et al. (2002) PYPAF1: A PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J. Biol. Chem. 277, 11570-11575
7. Richards, N. et al. (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 276, 39320-39329
8. Houten, S.M. et al. (1999) Mutations in MVK. encoding mevalonate kinase, cause hyperimmunoglobulinemia D and periodic fever syndrome. Nat. Genet. 22, 175-177
9. Drenth, J.P.H. et al. (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat. Genet. 22, 178-181
10. McDermott, M.F. et al. (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNF-R1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133-144
11. Bodmer, J.L. et al. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26
12. Hoffman, H.M. et al. (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29, 301-305
13. Dodé, C. et al. (2002) New mutations of C1AS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria; a novel mutation underlies both syndromes. Am. J. Hum. Genet. 70, 1498-1506
14. Aganna, E. et al. (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fevers, cold sensitivity, sensorineural deafness and AA amyloidosis. Arthritis Rheum. 46, 2445-2452
15. Martinon, F. et al. (2001) The pyrin domain: A possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 11, R118-R120
16. Aksentijevich, I. et al. (2001) The TNF receptor-associated periodic syndrome (TRAPS): New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am. J. Hum. Genet. 69, 301-314
17. Touitou, I. et al. (2000) MEFV mutations in Behcet's disease. Hum. Mutat. 16, 271-272
18. Livneh, A. et al. (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD). Eur. J. Hum. Genet. 9, 191-196
19. Bernot, A. et al. (1998) Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum. Mol. Genet. 7, 1317-1325
20. Touitou, I. (2001) The spectrum of familial Mediterranean fever (FMF) mutations. Eur. J. Hum. Genet. 9, 473-483
21. Cazeneuve, C. et al. (1999) MEFV-gene analysis in Armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - Genetic and therapeutic implications. Am. J. Hum. Genet. 65, 88-97
22. Touitou, I. et al. (2001) The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum. 44, 163-169
23. Cazeneuve, C. et al. (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am. J. Hum. Genet. 67, 1136-1143
24. Centola, M. et al. (2000) The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95, 3223-3231
25. Dodé, C. et al. (2000) A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family. Arthritis Rheum. 43, 1535-1542
26. Jadoul, M. et al. (2001) Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene. Kidney Int. 59, 1677-1682
27. Rosen-Wolff, A. et al. (2001) Periodic fever (TRAPS) caused by mutations in the TNFα receptor 1 (TNFRSF1A) gene of three German patients. Eur. J. Haematol. 67, 105-109
28. Simon, A. et al. (2001) Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene. Am. J. Med. 110, 313-315
29. Nevala, H. et al. (2002) A novel mutation in the third extracellular domain of the TNF receptor 1 (TNFRSF1A) in a Finnish family with autosomal dominant recurrent fever. Arthritis Rheum. 46, 1061-1066
30. Aganna, E. et al. (2002) An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor associated periodic syndrome (TRAPS). Arthritis Rheum. 46, 245-249
31. Aganna, E. et al. (2001) Tumor necrosis factor receptor associated periodic syndrome (TRAPS) in a Dutch family. Evidence for a TNFRSF1A mutation with reduced penetrance. Eur. J. Hum. Genet. 9, 63-66
32. Dodé, C. et al. (2002) Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks. Nephrol. Dial. Transplant. 17, 1212-1217
33. Dodé, C. et al. (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 46, 2181-2188
34. Frenkel, J. et al. (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatol. 40, 579-584
35. Cuisset, L. et al. (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur. J. Hum. Genet. 9, 260-266
36. Cuisset, L. et al. (1999) Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am. J. Hum. Genet. 65, 1054-1059
37. Hoffman, H.M. et al. (2000) Identification of a locus on chromosome 1q44 for Familial Cold Urticaria. Am. J. Hum. Genet. 66, 1693-1698
38. McDermott, M.F. et al. (2000) An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q. Arthritis Rheum. 43, 2034-2040
39. Koonin, E.V. and Aravind, L. (2000) The NACHT family - A new group of predicted NTPases implicated in apoptosis and MHC transcription activation. Trends Biochem. Sci. 25, 223-224
40. Feldmann, J. et al. (2002) Chronic Infantile Neurological Cutaneous and Articular Syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 71, 198-203
41. Prieur, A.M. (2001) A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin. Exp. Rheumatol. 19, 103-106
42. Miceli-Richard, C. et al. (2001) CARD 15 mutations in Blau syndrome. Nat. Genet. 29, 19-20
43. Hugot, J.P. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603
44. Ogura, Y. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606
45. Poltorak, A. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088
46. Lorenz, E. et al. (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162, 1028-1032
47. Zemer, D. et al. (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N. Engl. J. Med. 314, 1001-1005
48. Galon, J. et al. (2000) TNFRSF1A mutations and autoinflammatory syndromes. Curr. Opin. Immunol. 12, 479-486
49. Drewe, E. et al. (2000) Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N. Engl. J. Med. 343, 1044-1045
50. Hull, K.M. et al. (2002) Hereditary periodic fever. N. Engl. J. Med. 346, 1415-1416
51. Moreland, L.W. (1999) Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis. Clevel. Clin. J. Med. 66, 367-374
52. Schuna, A.A. and Megeff, C. (2000) New drugs for the treatment of rheumatoid arthritis. Am. J. Health Syst. Pharm. 57,225-237
53. Lipsky, P.E. et al. (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N. Engl. J. Med. 343, 1594-1602
54. Mohan, N. et al. (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum. 44, 2862-2869
55. Keane, J. et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 345, 1098-1104